We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bioinspired Approach to Sepsis Therapy
Video

Bioinspired Approach to Sepsis Therapy

Bioinspired Approach to Sepsis Therapy
Video

Bioinspired Approach to Sepsis Therapy

Wyss Institute Founding Director Don Ingber, Senior Staff Scientist Michael Super and Technology Development Fellow Joo Kang explain how they engineered the Mannose-binding lectin (MBL) protein to bind to a wide range of sepsis-causing pathogens and then safely remove the pathogens from the bloodstream using a novel microfluidic spleen-like device.

More information: http://wyss.harvard.edu/viewpressrelease/166/bloodcleansing-biospleen-device-developed-for-sepsis-therapy

Advertisement